HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults [Phase 3]
A Phase 3 clinical trial update assessing the long-term immunogenicity of Gardasil in HIV-infected adolescents and young adults.
-
FDA approval · 2012-01-18FDA Approved: VIREAD — Original Application (Gilead Sciences, Inc.)
FDA original approval of VIREAD (tenofovir disoproxil fumarate) by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Special Investigation of Kaletra in Pregnant Women
This document reports the completion of a special investigation of Kaletra (lopinavir/ritonavir) in pregnant women with HIV and notes that t…
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Phase IIB Pilot of Atazanavir + Raltegravir [Phase 2]
A Phase II trial evaluating the combination of atazanavir and raltegravir for HIV infection was terminated. Results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)
ClinicalTrials.gov entry for the CHARTA study, which measured adherence to antiretroviral therapy in HIV-infected children in Uganda, and is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand [Phase 3]
This update notes the completion of a Phase 3 trial monitoring Highly Active Antiretroviral Therapy in HIV-infected parents in Thailand.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine [Phase 2]
Phase 2 clinical trial assessing one-month dual antiretroviral prophylaxis to prevent resistance mutations in mothers exposed to a single-do…
-
CLINICAL_TRIALS trial_result · 2012-01-04Clinical Trial Update: Reducing Health Problems Associated With Injection Drug Use [NA]
A completed clinical trial evaluating strategies to reduce health problems related to intravenous drug use, including HIV infection.
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating retreatment with high-dose pegylated interferon alfa-2a and ribavirin in previous nonrespond…
-
FDA approval · 2011-12-30FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine submitted by Aurobindo Pharma Limited under an ANDA, authorizing changes to the appro…
-
CLINICAL_TRIALS trial_result · 2011-12-28Clinical Trial Update: A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents [Phase 2]
Phase 2 study evaluating antiviral activity of darunavir plus ritonavir in HIV-1 infected adolescents; results of the completed trial were p…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults [Phase 1]
Phase 1 trial assessing telephone-delivered behavioral interventions to reduce risky sexual behavior in HIV-positive older adults. The study…
-
FDA approval · 2011-12-21FDA Approved: ISENTRESS — Original Application (Merck Sharp & Dohme LLC)
FDA approved ISENTRESS (raltegravir) in its original application for HIV-1 infection.
-
FDA approval · 2011-12-21FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Isentress (raltegravir) filed by Merck Sharp & Dohme LLC, resulting in an approved change to the…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries [NA]
A completed clinical trial evaluating couple-oriented prenatal HIV counseling in low- and medium-prevalence countries, focusing on partner t…
-
FDA approval · 2011-12-16FDA Approved: PREZISTA — Original Application (Janssen Products LP)
This document announces the original FDA approval of PREZISTA (darunavir) for HIV-1 infection.
-
FDA approval · 2011-12-16FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients [Phase 3]
This Phase 3 trial update reports on the immunogenicity and tolerability of two strategies for Hepatitis A vaccination in HIV-infected patie…
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon [Phase 2, Phase 3]
The update summarizes results from Phase 2/3 trials examining acyclovir to suppress HIV-1 and HSV-2 coinfection in Cameroon.
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
A completed clinical trial evaluated Kaletra's impact on resistance to antiretrovirals in people with HIV infection.
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: An Expanded Safety Study of Dapivirine Gel 4789 in Africa [Phase 1, Phase 2]
An expanded safety study of the dapivirine vaginal gel (4789) in Africa has completed Phase 1/2 trials to assess safety for HIV prevention.
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) [Phase 2]
This update describes a Phase 2 clinical trial (ANRS 12103 BURKINAME) evaluating a once-daily highly active antiretroviral regimen in HIV-1 …
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) [Phase 2]
Phase 2 trial update of Tenofovir disoproxil fumarate/emtricitabine for preventing mother-to-child transmission of HIV in Africa and Asia. T…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
The document reports completion of a laboratory study evaluating licensed H1N1 influenza vaccines in HIV-1 perinatally infected children and…
-
FDA approval · 2011-12-02FDA Approved: LAMIVUDINE — Original Application (Apotex Corp.)
FDA approves Apotex Corp.'s original application for lamivudine (generic), authorizing its marketing for HIV-1 infection and chronic hepatit…